These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 14645875)
21. Radiofrequency thermal ablation in the treatment of lung malignancies. Gadaleta C; Catino A; Mattioli V In Vivo; 2006; 20(6A):765-7. PubMed ID: 17203764 [TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients. Gunabushanam G; Sharma S; Thulkar S; Srivastava DN; Rath GK; Julka PK; Bhatnagar S J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):67-72. PubMed ID: 17296706 [TBL] [Abstract][Full Text] [Related]
23. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment. Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017 [TBL] [Abstract][Full Text] [Related]
24. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160 [TBL] [Abstract][Full Text] [Related]
25. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427 [TBL] [Abstract][Full Text] [Related]
26. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763 [TBL] [Abstract][Full Text] [Related]
27. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [TBL] [Abstract][Full Text] [Related]
28. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462 [TBL] [Abstract][Full Text] [Related]
29. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181 [TBL] [Abstract][Full Text] [Related]
30. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555 [TBL] [Abstract][Full Text] [Related]
31. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. Rhim H; Lim HK; Kim YS; Choi D J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e422-7. PubMed ID: 17944897 [TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience. Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676 [TBL] [Abstract][Full Text] [Related]
33. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study. Ambrogi MC; Fontanini G; Cioni R; Faviana P; Fanucchi O; Mussi A J Thorac Cardiovasc Surg; 2006 May; 131(5):1002-6. PubMed ID: 16678582 [TBL] [Abstract][Full Text] [Related]
34. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597 [TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation of lung tumors. Casal RF; Tam AL; Eapen GA Clin Chest Med; 2010 Mar; 31(1):151-63, Table of Contents. PubMed ID: 20172441 [TBL] [Abstract][Full Text] [Related]
36. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lencioni R; Crocetti L; Cioni R; Suh R; Glenn D; Regge D; Helmberger T; Gillams AR; Frilling A; Ambrogi M; Bartolozzi C; Mussi A Lancet Oncol; 2008 Jul; 9(7):621-8. PubMed ID: 18565793 [TBL] [Abstract][Full Text] [Related]
38. [Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]. De Baere T; Elias D; Ducreux M; Dromain C; Kuach V; Gamal El Din M; Sobotka A; Lasser P; Roche A Gastroenterol Clin Biol; 1999 Nov; 23(11):1128-33. PubMed ID: 10651531 [TBL] [Abstract][Full Text] [Related]
39. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378 [TBL] [Abstract][Full Text] [Related]